Sarah Gogo-Cohen

555, University Avenue
Toronto, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.

Pathway for the Development of ATR Inhibitors in Pediatric Malignancies: An ACCELERATE Multistakeholder Analysis.

Journal: JCO precision oncology

Published: January 15, 2026

Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.

Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes.

Journal: JCO precision oncology

Published: August 01, 2025

The Evolution of Pneumocystis jirovecii Pneumonia Prophylaxis for Pediatric Patients With Extracranial Solid Tumors: A Review of Historical Insights and Future Directions.

The Evolution of Pneumocystis jirovecii Pneumonia Prophylaxis for Pediatric Patients With Extracranial Solid Tumors: A Review of Historical Insights and Future Directions.

Journal: Pediatric blood & cancer

Published: June 26, 2025

A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors.

A Quality Improvement Initiative to Standardize Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Patients With Solid Tumors.

Journal: Pediatric blood & cancer

Published: June 26, 2025

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Journal: Molecular cancer therapeutics

Published: April 29, 2025

Early phase study enrollment in Canadian children with cancer near end of life: A retrospective cohort study from Cancer in Young People in Canada.

Early phase study enrollment in Canadian children with cancer near end of life: A retrospective cohort study from Cancer in Young People in Canada.

Journal: Cancer

Published: April 18, 2025

New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee.

New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee.

Journal: Pediatric blood & cancer

Published: February 11, 2025

Comment on: Incidence of Adrenal Insufficiency in Patients with High-Risk Neuroblastoma: A Single-Institution Analysis.

Comment on: Incidence of Adrenal Insufficiency in Patients with High-Risk Neuroblastoma: A Single-Institution Analysis.

Journal: Pediatric blood & cancer

Published: January 28, 2025

Assessing the Impact of u-link.care: Implementation of a Pediatric Cancer Clinical Trials Finder Website to Improve Healthcare Provider Knowledge and Identify Barriers to Enrollment.

Assessing the Impact of u-link.care: Implementation of a Pediatric Cancer Clinical Trials Finder Website to Improve Healthcare Provider Knowledge and Identify Barriers to Enrollment.

Journal: Pediatric blood & cancer

Published: January 15, 2025

Clinical utility of targeted RNA sequencing in cancer molecular diagnostics.

Clinical utility of targeted RNA sequencing in cancer molecular diagnostics.

Journal: Nature medicine

Published: November 22, 2024

DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition.

DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition.

Journal: Cell reports

Published: October 11, 2024

Comment on: Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer.

Comment on: Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer.

Journal: Pediatric blood & cancer

Published: August 19, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026